Weight Management Solutions
Understanding the Risks of Obesity
Obesity is associated with serious health risks, including an increased likelihood of cardiovascular disease, diabetes, hypertension, and other medical conditions. Several factors contribute to obesity, including:
- Increased consumption of high-sugar, high-fat foods
- Sedentary lifestyles and reduced physical activity
- Genetic predispositions and external influences
To effectively manage weight, a combination of strategies is often necessary, including:
- Dietary Adjustments: Focus on reducing processed and high-fat foods while increasing the intake of nutrient-dense, high-fiber options.
- Physical Activity: Regular exercise is essential for long-term weight management.
- Surgical Interventions: For severe obesity, bariatric surgery can alter the digestive system to aid in weight loss.
- Weight Management Programs: Tailored plans created by specialists that combine diet, physical activity, and habit adjustments.
- Weight Loss Medications: Prescribed alongside lifestyle changes, compounded weight loss medications offer personalized treatment options to enhance weight loss efforts.
Weight Loss Medications: GLP-1 and GIP Receptor Agonists
GLP-1 and GIP receptor agonists are commonly used to help manage blood sugar levels in adults with type 2 diabetes. These medications increase insulin production after meals, reduce sugar release from the liver, and slow stomach emptying, which promotes a sense of fullness and may help support weight loss over time. Weight management medications may work best when combined with a healthy diet and regular physical activity.
Porter’s Compounding Pharmacy has been offering both injectable and sublingual forms of semaglutide. We obtained the injectable form from a qualified 503B compounding pharmacy and the sublingual form is compounded right here in our own pharmacy compounding lab.
Federal guidance has allowed Porter’s, a 503A compounding pharmacy, to access injectable semaglutide from a 503B because commercial injectable semaglutide was in short supply and the FDA put it on their “Drug Shortage List.” We have been able to sell it out of our pharmacy over the past year’s time frame because of this.
However, commercial injectable semaglutide has been recently removed from the FDA Drug Shortage List because the FDA deems that the drug company who manufactures their brand of semaglutide can now sufficiently manufacture it to be able to supply the market. As a result, we now must comply with FDA rules and begin to segway away from selling compounded semaglutide, that is unless current court filings come back with a result that allows us to continue.
Please read the attached Frequently Asked Questions document below to help you understand more about this and to see what options you and your healthcare provider may have during this transition period. We will still be able to continue offering the sublingual version of semaglutide and will continue making it in our compounding lab on site.
Overcoming Weight Management Challenges
Many individuals encounter obstacles on their weight management journey, such as physical discomfort, fatigue, medical conditions, and hormonal imbalances. Environmental factors, like limited time or access to healthy foods, also play a role. At Porter’s, we recognize these challenges and are here to help by providing customized weight management medications designed to address your individual needs.